Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 217433 (Jul 15, 2024)

Issued July 15, 2024

Issued

July 15, 2024

Application

NDA 505b1 • 217433

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due July 15, 2025Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…